| Literature DB >> 11314620 |
H G Moghadam1, M R Urist, G K Sandor, C M Clokie.
Abstract
A bone morphogenetic protein bioimplant was used for primary reconstruction of a 6-cm mandibular discontinuity defect, after a segmental resection of an ameloblastoma. Radiographic evidence of new bone induction was seen at 3 and 9 months, postoperatively. A biopsy was taken at 9 months demonstrated viable new bone formation at the bioimplant site. This is the first reported case using a bone morphogenetic protein bioimplant in a human, followed by histological confirmation of new bone.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11314620 DOI: 10.1097/00001665-200103000-00005
Source DB: PubMed Journal: J Craniofac Surg ISSN: 1049-2275 Impact factor: 1.046